As of Nov 11, 2026, OpinionKings traders give a 35% probability that a confirmed human case of Ebola disease in Central African Republic is officially reported before Jan 1, 2027. 17 outcomes · resolves Dec 31, 2026.
1. Winning shares pay out $1.00 each upon market resolution; all others settle at $0.00.
2. Trades execute at the current market price unless a limit order is placed.
3. Limit orders remain active until filled, cancelled, or the market closes.
4. Shares can be sold any time before the market closes.
5. Markets may be suspended or cancelled for ambiguous outcomes.
6. All balances and positions are denominated in USD.
Each outcome settles on its own terms. For “Central African Republic”: If a confirmed human case of Ebola disease in Central African Republic is officially reported after Issuance and before Jan 1, 2027, then the market resolves to Yes. Only confirmed cases qualify; suspected, probable, or presumptive cases do not. Animal cases do not qualify. The case must be confirmed in Central African Republic — a citizen of Central African Republic diagnosed elsewhere does not count. Imported cases diagnosed within Central African Republic do count. Resolved using Bloomberg, CDC and New York Times.
This Science and Technology market on OpinionKings has 17 outcomes. “Central African Republic” leads at 35%, down from 58% a week ago. The next most likely outcome, “South Sudan”, is at 23%. Each price is the probability traders currently assign to that outcome, and it moves as they buy and sell. Trading closes Dec 31, 2026.
